Clinical Trial Update: Study to Determine the Pharmacokinetics of Product 0405 [Phase 3]

View source ↗

Summary

A Phase 3 pharmacokinetics study of Product 0405 sponsored by Fougera Pharmaceuticals Inc. for Atopic Dermatitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Product 0405

Snippet

Sponsor: Fougera Pharmaceuticals Inc. | Conditions: Atopic Dermatitis | Phase 3 | Status: WITHDRAWN